Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Moutschen, Michel" or (type any "bookEditor journalEditor issueEditor" and editor="Moutsc...

Add to list
- Journal Article
- A1
- open access
Early high antibody titre convalescent plasma for hospitalised COVID-19 patients : DAWn-plasma

Timothy Devos, Quentin Van Thillo, Veerle Compernolle (UGent) , Tomé Najdovski, Marta Romano, Nicolas Dauby, Laurent Jadot, Mathias Leys, Evelyne Maillart, Sarah Loof, et al.

(2022) EUROPEAN RESPIRATORY JOURNAL. 59.
Add to list
Clinical characteristics and outcomes of COVID‐19 in people living with HIV in Belgium : a multicenter, retrospective cohort

Rakan Nasreddine, Eric Florence, Michel Moutschen, Jean‐Cyr Yombi, Jean‐Christophe Goffard, Inge Derdelinckx, Patrick Lacor, Linos Vandekerckhove (UGent) , Peter Messiaen, Stefaan Vandecasteele, et al.

(2021) JOURNAL OF MEDICAL VIROLOGY. 93(5). p.2971-2978
Add to list
- Journal Article
- A1
- open access
Association between convalescent plasma treatment and mortality in COVID-19 : a collaborative systematic review and meta-analysis of randomized clinical trials

Cathrine Axfors, Perrine Janiaud, Andreas M. Schmitt, Janneke van’t Hooft, Emily R. Smith, Noah A. Haber, Akin Abayomi, Manal Abduljalil, Abdulkarim Abdulrahman, Yeny Acosta-Ampudia, et al.

(2021) BMC INFECTIOUS DISEASES. 21(1).
Add to list
- Journal Article
- A1
- open access
A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventilation : the CONFIDENT trial protocol

Benoît Misset, Eric Hoste (UGent) , Anne-Françoise Donneau, David Grimaldi, Geert Meyfroidt, Michel Moutschen, Veerle Compernolle, André Gothot, Daniel Desmecht, Mutien Garigliany, et al.

(2020) BMC PULMONARY MEDICINE. 20(1).
Add to list
- Journal Article
- A1
- open access
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19 : the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

Timothy Devos, Tatjana Geukens, Alexander Schauwvlieghe (UGent) , Kevin K. Arien, Cyril Barbezange, Myriam Cleeren, Veerle Compernolle, Nicolas Dauby, Daniel Desmecht, David Grimaldi, et al.

(2020) TRIALS. 21(1).
Add to list
Long-term use of darunavir/ritonavir-containing regimens in daily practice in Belgium : retrospective observational cohort data of 1701 HIV-patients

Stéphane De Wit, Eric Florence, Linos Vandekerckhove (UGent) , Bernard Vandercam, Jean-Christophe Goffard, Eric Van Wijngaerden, Michel Moutschen, Remy Demeester, Pushpike Thilakarathne and Hilde Piryns

(2018) ACTA CLINICA BELGICA. 73(5). p.341-347
Add to list
- Journal Article
- A1
- open access
Prevalence of non-infectious comorbidities in the HIV-positive population in Belgium : a multicenter, retrospective study

Jessie Gunter, Steven Callens (UGent) , Stephane De Wit, Jean-Christophe Goffard, Michel Moutschen, Gilles Darcis, Christelle Meuris, Charlotte van den Bulcke, Karine Fombellida, Marc del Forge, et al.

(2018) ACTA CLINICA BELGICA. 73(1). p.50-53
Add to list
DUSP3 genetic deletion confers M2-like macrophage-dependent tolerance to septic shock

Pratibha Singh, Lien Dejager (UGent) , Mathieu Amand, Emilie Theatre, Maud Vandereyken, Tinatin Zurashvili, Maneesh Singh, Matthias Mack, Steven Timmermans (UGent) , Lucia Musumeci, et al.

(2015) JOURNAL OF IMMUNOLOGY. 194(10). p.4951-4962
Add to list
- Conference Paper
- C3
- open access
Factors associated with the continuum of care of HIV infected patients in Belgium

Dominique Van Beckhoven, Patrick Lacor, Michel Moutschen, Denis Piérard, André Sasse, Dolorès Vaira, Sigi Van den Wijngaert, Bernard Vandercam, Marc Van Ranst, Eric Van Wijngaerden, et al.

(2014) JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 17(suppl. 3). p.30-31
Add to list
- Journal Article
- A1
- open access
Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment

Linos Vandekerckhove (UGent) , Chris Verhofstede (UGent) , Els Demecheleer (UGent) , Stephane De Wit, Eric Florence, Katrien Fransen, Michel Moutschen, Wendy Mostmans, Kabamba Kabeya, Nicola Mackie, et al.

(2011) JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 66(2). p.265-272

Academic Bibliography

Early high antibody titre convalescent plasma for hospitalised COVID-19 patients : DAWn-plasma

Clinical characteristics and outcomes of COVID‐19 in people living with HIV in Belgium : a multicenter, retrospective cohort

Association between convalescent plasma treatment and mortality in COVID-19 : a collaborative systematic review and meta-analysis of randomized clinical trials

A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventilation : the CONFIDENT trial protocol

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19 : the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

Long-term use of darunavir/ritonavir-containing regimens in daily practice in Belgium : retrospective observational cohort data of 1701 HIV-patients

Prevalence of non-infectious comorbidities in the HIV-positive population in Belgium : a multicenter, retrospective study

DUSP3 genetic deletion confers M2-like macrophage-dependent tolerance to septic shock

Factors associated with the continuum of care of HIV infected patients in Belgium

Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment

Contents

Support

Contact